MedPath

Recordati Rare Diseases, Inc.

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.recordatirarediseases.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

FDA:8

Drug Approvals

Panhematin

Approval Date
Feb 14, 2024
FDA

CYSTADROPS

Approval Date
Feb 1, 2024
FDA

Signifor LAR

Approval Date
Jan 24, 2024
FDA

Cosmegen

Approval Date
Jan 18, 2024
FDA

Isturisa

Approval Date
Nov 3, 2023
FDA

NEOPROFEN

Approval Date
Nov 2, 2023
FDA

Signifor

Approval Date
Aug 3, 2023
FDA

Chemet

Approval Date
Jan 11, 2023
FDA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.